Wharton's Jelly and Exosome Supplier for Knoxville Orthopedics

Vendor qualification for orthopedic accounts

Orthopedic practices and ambulatory surgery centers typically run new suppliers through a standard intake process before the first order: confirming the supplier's registration status, requesting sample documentation for a representative lot, and routing the review through a medical director or compliance lead. Because Wharton's jelly allografts and exosome products sit in different regulatory categories, many practices keep separate checklists for each product family rather than treating a single vendor review as sufficient for both. A written record of that review, not just a verbal approval, is what most compliance files expect to see at renewal.

Cold-chain logistics into the Southeast

Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers and are stored at -80 degrees Celsius until use; lyophilized formats are shelf-stable and do not require cryogenic storage. Practices in the Knoxville area should plan for overnight delivery scheduling and a receiving process that logs each shipment's temperature indicator and lot number on arrival. Because each lot carries a unique identifier, intake staff should be able to match the delivered product to its certificate of analysis before it is placed into inventory.

Documentation and oversight

Before using any product clinically, practices generally confirm with their own medical director and legal counsel whether a specific intended use fits within their regulatory framework, and separately verify their license status with the Tennessee Board of Medical Examiners or applicable state board. Precision Biologics does not advise on clinical use, dosing, or procedure protocols; documentation such as a certificate of analysis, donor eligibility summary, and lot release record is made available to verified accounts so that review can happen internally.

Setting up an account

Opening an account starts with NPI verification against the NPPES registry, after which a Precision Biologics contact can schedule a peer-to-peer conversation focused on product documentation rather than clinical guidance. Pricing is available to verified accounts only, and orders are limited to licensed healthcare professionals.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.